BMS-986020
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BMS-986020, covering 2014-06-02 to 2016-07-22. Get the full timeline:
Most recent: Clinical Trial Update: A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc) [Phase 2]